BAYSTATE WEALTH MANAGEMENT LLC – Alnylam Pharmaceuticals, Inc. Transaction History
BAYSTATE WEALTH MANAGEMENT LLC portfolio value:
$105,000
portfolio value
BAYSTATE WEALTH MANAGEMENT LLC quarter portfolio value change:
+37.24%
quarter
Alnylam Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | 0.00% | 0 shares | 28K | $200.16 | 527 | |
Q2 2022 | share | 0.00% | 0 shares | -9K | $145.85 | 527 | |
Q1 2022 | share | Decrease | -50.05% | -528 shares | -93K | $163.29 | 527 |
Q4 2021 | share | 0.00% | 0 shares | -20K | $171.03 | 1.05K | |
Q3 2021 | share | 0.00% | 0 shares | 20K | $188.81 | 1.05K | |
Q2 2021 | share | 0.00% | 0 shares | 30K | $169.52 | 1.05K | |
Q1 2021 | share | Increase | 0.00% | 1.05K shares | 149K | $141.19 | 1.05K |
Q1 2017 | share | Decrease | -100.00% | -460 shares | -19K | $51.25 | 0 |
Q4 2016 | share | Increase | 0.00% | 460 shares | 19K | $37.44 | 460 |